Hainan Huluwa Pharmaceutical Group Co.,Ltd.’s Net Profit Rose 10.3% in First Half of 2023

Hainan Huluwa Pharmaceutical Group Co.,Ltd. (海南葫芦娃药业集团股份有限公司) (605199.SH) reported a net profit of 63.2 million yuan in the first half of 2023, up 10.3% year-on-year.

Meanwhile, the company posted 914 million yuan in revenue, up 24.6% year-on-year.

At the end of the reporting period, it had 2.5 billion yuan in total assets and 1.4 billion yuan in total liabilities, with a liability-to-asset ratio of 56.3%.